{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:27:32Z","timestamp":1790422052435,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.parkreldis.2014.11.007","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T17:54:33Z","timestamp":1416506073000},"page":"87-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice"],"prefix":"10.1016","volume":"21","author":[{"given":"Fang","family":"Ba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.R. Wayne","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2014.11.007_bib1","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","article-title":"Alzheimer's disease and Parkinson's disease","volume":"348","author":"Nussbaum","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S0317167100031814","article-title":"Accuracy of clinical diagnosis in parkinsonism \u2013 a prospective study","volume":"18","author":"Rajput","year":"1991","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib4","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/mds.22829","article-title":"Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland","volume":"24","author":"Newman","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib5","first-page":"999","article-title":"Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients","volume":"44","author":"Huang","year":"2003","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib6","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications","volume":"318","author":"Kish","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib7","first-page":"353","article-title":"The role of neuroimaging in the early diagnosis and evaluation of Parkinson's disease","volume":"96","author":"Seibyl","year":"2005","journal-title":"Minerva Med"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib8","first-page":"584","article-title":"Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers","volume":"41","author":"Mozley","year":"2000","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.pneurobio.2011.08.009","article-title":"Imaging biomarkers in Parkinson's disease","volume":"95","author":"Brooks","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00259-003-1331-x","article-title":"Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson's disease","volume":"31","author":"Huang","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib11","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/brain\/awr177","article-title":"The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration","volume":"134","author":"Cummings","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2967\/jnmt.112.111617","article-title":"A\u00a0new era of clinical dopamine transporter imaging using 123I-FP-CIT","volume":"40","author":"Park","year":"2012","journal-title":"J\u00a0Nucl Med Technol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib13","unstructured":"Website EMApifD. 2000."},{"key":"10.1016\/j.parkreldis.2014.11.007_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00259-009-1267-x","article-title":"EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2","volume":"37","author":"Darcourt","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib15","unstructured":"DaTscan Fpif. 2011."},{"key":"10.1016\/j.parkreldis.2014.11.007_bib16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1590\/S0004-282X2012000900004","article-title":"Dopamine transporter imaging in clinically unclear cases of parkinsonism and the importance of scans without evidence of dopaminergic deficit (SWEDDs)","volume":"70","author":"Utiumi","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib17","first-page":"S97","article-title":"Effective and efficient diagnosis of parkinsonism: the role of dopamine transporter SPECT imaging with ioflupane I-123 injection (DaTscan)","volume":"20","author":"Cummings","year":"2014","journal-title":"Am J Manag Care"},{"issue":"Pt 8","key":"10.1016\/j.parkreldis.2014.11.007_bib18","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/brain\/122.8.1449","article-title":"Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution","volume":"122","author":"Piggott","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00259-008-0989-5","article-title":"Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls","volume":"36","author":"Eshuis","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib21","first-page":"439","article-title":"Investigating the dopaminergic synapse in\u00a0vivo. I. Molecular imaging studies in humans","volume":"18","author":"Nikolaus","year":"2007","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1212\/WNL.46.1.231","article-title":"[123I] beta-CIT\/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease","volume":"46","author":"Marek","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ana.20160","article-title":"Idiopathic hyposmia as a preclinical sign of Parkinson's disease","volume":"56","author":"Ponsen","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib24","first-page":"745","article-title":"Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene","volume":"46","author":"van Dyck","year":"2005","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ana.410380407","article-title":"Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease","volume":"38","author":"Seibyl","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","article-title":"Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov Disord"},{"issue":"Suppl.\u00a07","key":"10.1016\/j.parkreldis.2014.11.007_bib27","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1002\/mds.10579","article-title":"Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?","volume":"18","author":"Pirker","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","article-title":"In\u00a0vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease","volume":"47","author":"Lee","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/mds.25828","article-title":"Reversible dopamine transporter reduction in drug-induced parkinsonism","volume":"29","author":"Cilia","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib30","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/brain\/awh607","article-title":"PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation","volume":"128","author":"Adams","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/ana.410340304","article-title":"Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels","volume":"34","author":"Snow","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib32","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1136\/jnnp.2009.193391","article-title":"Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study","volume":"81","author":"Bajaj","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00002826-200001000-00007","article-title":"A\u00a0randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: design and methods of the CALM-PD study. Parkinson Study Group","volume":"23","year":"2000","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","article-title":"Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002590000460","article-title":"The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism","volume":"28","author":"Booij","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib36","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/mds.20112","article-title":"Impact of dopamine transporter SPECT using 123I-ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes","volume":"19","author":"Catafau","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib37","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/archneur.61.8.1224","article-title":"(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in parkinsonian syndrome: unmasking an early diagnosis","volume":"61","author":"Jennings","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib38","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/01.mnm.0000243374.11260.5b","article-title":"Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging","volume":"27","author":"Marshall","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.22108","article-title":"Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT","volume":"24","author":"Marshall","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib40","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1468-1331.2012.03875.x","article-title":"I123-FP-CIT single-photon emission tomography in patients with long-standing mixed tremor","volume":"20","author":"de Verdal","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib41","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.0000000000000424","article-title":"Longitudinal follow-up of SWEDD subjects in the PRECEPT study","volume":"82","author":"Marek","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib42","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pbb.2007.10.013","article-title":"Effect of chronic lithium treatment on D2\/3 autoreceptor regulation of dopaminergic function in the rat","volume":"90","author":"Ferrie","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib43","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/1531-8249(200006)47:6<804::AID-ANA14>3.0.CO;2-F","article-title":"Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT","volume":"47","author":"Nurmi","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib44","first-page":"1","article-title":"Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease","volume":"38","author":"Asenbaum","year":"1997","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib45","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson's disease","volume":"351","author":"Fahn","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/01.WNL.0000149403.14458.7F","article-title":"The role of radiotracer imaging in Parkinson disease","volume":"64","author":"Ravina","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib47","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1212\/WNL.0000000000000821","article-title":"Novel DYT11 gene mutation in patients without dopaminergic deficit (SWEDD) screened for dystonia","volume":"83","author":"Cilia","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.parkreldis.2013.01.013","article-title":"Evidence of delayed nigrostriatal dysfunction in corticobasal syndrome: a SPECT follow-up study","volume":"19","author":"Ceravolo","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib49","first-page":"1410","article-title":"Normal dopamine transporter SPECT in neuropathologically confirmed corticobasal degeneration","volume":"260","author":"Kaasinen","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib50","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/mds.25157","article-title":"Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease","volume":"27","author":"Ravina","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.parkreldis.2011.04.002","article-title":"Estimation of further disease progression of Parkinson's disease by dopamine transporter scan vs clinical rating","volume":"17","author":"Vogt","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib52","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ana.22284","article-title":"Age-specific progression of nigrostriatal dysfunction in Parkinson's disease","volume":"69","author":"de la Fuente-Fernandez","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib53","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson's disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.parkreldis.2014.11.007_bib54","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/S1353-8020(13)70042-7","article-title":"Developments in neuroimaging: positron emission tomography","volume":"20","author":"Stoessl","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib55","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00702-005-0382-5","article-title":"Brain SPECT imaging in multiple system atrophy","volume":"112","author":"Cilia","year":"2005","journal-title":"J\u00a0Neural Transm"},{"issue":"Pt 1B","key":"10.1016\/j.parkreldis.2014.11.007_bib56","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/brain\/114.1.541","article-title":"Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography","volume":"114","author":"Sawle","year":"1991","journal-title":"Brain"},{"issue":"Suppl.\u00a07","key":"10.1016\/j.parkreldis.2014.11.007_bib57","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1002\/mds.10574","article-title":"Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders","volume":"18","author":"Marshall","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib58","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mds.10042","article-title":"Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP","volume":"17","author":"Kim","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib59","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/mds.1256","article-title":"[(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy","volume":"16","author":"Varrone","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib60","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00259-004-1578-x","article-title":"Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy","volume":"31","author":"Knudsen","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.mnm.0000202858.45522.df","article-title":"123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study","volume":"27","author":"Filippi","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/mds.24000","article-title":"Dopamine transporter imaging in autopsy-confirmed Parkinson's disease and multiple system atrophy","volume":"27","author":"Perju-Dumbrava","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib63","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s00259-010-1681-0","article-title":"A\u00a0novel computer-assisted image analysis of [123I]beta-CIT SPECT images improves the diagnostic accuracy of parkinsonian disorders","volume":"38","author":"Goebel","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib64","doi-asserted-by":"crossref","first-page":"e18301","DOI":"10.1371\/journal.pone.0018301","article-title":"Dopamine transporter SPECT imaging in corticobasal syndrome","volume":"6","author":"Cilia","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib65","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/mds.22323","article-title":"Normal dopamine transporter single photon-emission CT scan in corticobasal degeneration","volume":"23","author":"O'Sullivan","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib66","doi-asserted-by":"crossref","first-page":"e69190","DOI":"10.1371\/journal.pone.0069190","article-title":"Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis","volume":"8","author":"McNeill","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib67","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/mds.21861","article-title":"Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor","volume":"23","author":"Doepp","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib68","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1600-0404.2005.00517.x","article-title":"99mTc-TRODAT-1 SPECT study in early Parkinson's disease and essential tremor","volume":"112","author":"Wang","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00702-005-0311-7","article-title":"[(11)C]d-Threo-methylphenidate PET in patients with Parkinson's disease and essential tremor","volume":"113","author":"Breit","year":"2006","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib70","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s007020050124","article-title":"[123I]beta-CIT and SPECT in essential tremor and Parkinson's disease","volume":"105","author":"Asenbaum","year":"1998","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib71","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/mds.22870","article-title":"Imaging essential tremor","volume":"25","author":"Isaias","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib72","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.2008.147223","article-title":"Risk of incident Parkinson's disease and parkinsonism in essential tremor: a population based study","volume":"80","author":"Benito-Leon","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib73","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/mds.22161","article-title":"Emergence of Parkinson's disease in essential tremor: a study of the clinical correlates in 53 patients","volume":"23","author":"Minen","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib74","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/mds.10592","article-title":"Role of dopamine transporter imaging in routine clinical practice","volume":"18","author":"Marshall","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib76","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/mds.870100408","article-title":"Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases","volume":"10","author":"Mark","year":"1995","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib77","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mds.22937","article-title":"Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review","volume":"25","author":"Kalra","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib78","first-page":"408","article-title":"Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1","volume":"42","author":"Tzen","year":"2001","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib79","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.10092","article-title":"[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease","volume":"17","author":"Gerschlager","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib80","first-page":"1688","article-title":"123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism","volume":"45","author":"Lorberboym","year":"2004","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib81","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/mds.21479","article-title":"[123I] FP-CIT SPECT study in vascular parkinsonism and Parkinson's disease","volume":"22","author":"Zijlmans","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib82","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11940-009-0019-3","article-title":"Drug-induced parkinsonism","volume":"11","author":"Susatia","year":"2009","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib83","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S003329170003960X","article-title":"The pathophysiology of extrapyramidal side-effects of neuroleptic drugs","volume":"10","author":"Marsden","year":"1980","journal-title":"Psychol Med"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib84","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00259-009-1289-4","article-title":"Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson's disease","volume":"37","author":"Diaz-Corrales","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib85","doi-asserted-by":"crossref","DOI":"10.3410\/M1-82","article-title":"Recent imaging advances in the diagnosis and management of Parkinson's disease","volume":"1","author":"Brooks","year":"2009","journal-title":"F1000 Med Rep"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib86","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.20748","article-title":"[123I]-FP\/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease","volume":"21","author":"Lorberboym","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib87","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jnnp.2008.157370","article-title":"The role of DAT-SPECT in movement disorders","volume":"81","author":"Kagi","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib88","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/mds.21685","article-title":"Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs)","volume":"22","author":"Schneider","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib89","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/WCO.0b013e32832dc169","article-title":"Psychogenic movement disorders","volume":"22","author":"Gupta","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib90","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0031-1271312","article-title":"Diagnosis and treatment of common forms of tremor","volume":"31","author":"Puschmann","year":"2011","journal-title":"Semin Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib91","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/mds.20720","article-title":"Psychogenic parkinsonism: a combination of clinical, electrophysiological, and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracy","volume":"21","author":"Benaderette","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib92","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/mds.21062","article-title":"123I-Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism","volume":"21","author":"Gaig","year":"2006","journal-title":"Mov Disord"},{"issue":"Suppl.\u00a05","key":"10.1016\/j.parkreldis.2014.11.007_bib93","doi-asserted-by":"crossref","first-page":"v2","DOI":"10.1136\/jnnp.2005.082867","article-title":"Epidemiology and risk factors of dementia","volume":"76","author":"van der Flier","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib94","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/jnnp.62.1.16","article-title":"Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study","volume":"62","author":"Ala","year":"1997","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib95","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1093\/brain\/aws211","article-title":"Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias","volume":"135","author":"Colloby","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib96","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1099-1166(200009)15:9<794::AID-GPS178>3.0.CO;2-1","article-title":"Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study","volume":"15","author":"Samuel","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib97","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-2007-11412","article-title":"Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences","volume":"11","author":"Emre","year":"2007","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib98","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1533317506297517","article-title":"Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study","volume":"22","author":"Rozzini","year":"2007","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib99","first-page":"359","article-title":"Low sensitivity in clinical diagnoses of dementia with Lewy bodies","volume":"257","author":"Nelson","year":"2010","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MNM.0b013e328155d143","article-title":"Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies","volume":"28","author":"Kemp","year":"2007","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib101","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jalz.2007.11.016","article-title":"Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography","volume":"4","author":"Koeppe","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib102","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/jnnp.2006.110122","article-title":"Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy","volume":"78","author":"Walker","year":"2007","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib103","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/01.WNL.0000123248.39847.1D","article-title":"Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison","volume":"62","author":"Walker","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib104","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","article-title":"Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study","volume":"6","author":"McKeith","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib105","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib106","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1001\/archneurol.2012.574","article-title":"Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs","volume":"69","author":"Tadic","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib107","first-page":"1016","article-title":"Normal dopamine transporter binding in dopa responsive dystonia","volume":"249","author":"Huang","year":"2002","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib108","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000074914","article-title":"Clinical and [99mTc]TRODAT-1\/[123I]IBZM SPECT imaging findings in dopa-responsive dystonia","volume":"51","author":"Hwang","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib109","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ana.410430614","article-title":"Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia","volume":"43","author":"Jeon","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib110","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1212\/WNL.56.2.266","article-title":"SPECT imaging of the dopamine transporter in juvenile-onset dystonia","volume":"56","author":"O'Sullivan","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib111","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2377-3-6","article-title":"A\u00a0linkage study of candidate loci in familial Parkinson's disease","volume":"3","author":"Wirdefeldt","year":"2003","journal-title":"BMC Neurol"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib112","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1093\/brain\/awu179","article-title":"Parkinson's disease in GTP cyclohydrolase 1 mutation carriers","volume":"137","author":"Mencacci","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib113","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1212\/WNL.0b013e318248e520","article-title":"Role of DaTSCAN and clinical diagnosis in Parkinson disease","volume":"78","author":"de la Fuente-Fernandez","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib114","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.0b013e3182494c72","article-title":"To scan or not to scan: DaT is the question","volume":"78","author":"Perlmutter","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1552-6569.2011.00583.x","article-title":"[123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes","volume":"22","author":"Hauser","year":"2012","journal-title":"J\u00a0Neuroimaging"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib116","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/jnnp-2012-304436","article-title":"Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes","volume":"84","author":"Bajaj","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib117","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00019442-200201000-00005","article-title":"Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries","volume":"10","author":"van Dyck","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.parkreldis.2014.11.007_bib118","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1523\/JNEUROSCI.19-18-07699.1999","article-title":"Membrane trafficking regulates the activity of the human dopamine transporter","volume":"19","author":"Melikian","year":"1999","journal-title":"J\u00a0Neurosci"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802014004209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802014004209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T02:06:32Z","timestamp":1717553192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802014004209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1353802014004209"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2014.11.007","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2014.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}